Cargando…

An alternative method to analyse the biomarker‐strategy design

Recent developments in genomics and proteomics enable the discovery of biomarkers that allow identification of subgroups of patients responding well to a treatment. One currently used clinical trial design incorporating a predictive biomarker is the so‐called biomarker strategy design (or marker‐bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunz, Cornelia Ursula, Jaki, Thomas, Stallard, Nigel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6492198/
https://www.ncbi.nlm.nih.gov/pubmed/30260533
http://dx.doi.org/10.1002/sim.7940